Smilowitz Nathaniel R, Gupta Navdeep, Guo Yu, Bangalore Sripal
Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Am J Cardiol. 2016 Apr 1;117(7):1065-71. doi: 10.1016/j.amjcard.2015.12.050. Epub 2016 Jan 14.
Patients hospitalized with sepsis may be predisposed to acute myocardial infarction (AMI). The incidence, treatment, and outcomes of AMI in sepsis have not been studied. We analyzed data from the National Inpatient Sample from 2002 to 2011 for patients with a diagnosis of sepsis. The incidence of AMI as a nonprimary diagnosis was evaluated. Propensity score matching was used to identify a cohort of patients with secondary AMI and sepsis with similar baseline characteristics who were managed invasively (defined as cardiac catheterization, percutaneous coronary intervention [PCI], or coronary artery bypass graft [CABG] surgery) or conservatively. The primary outcome was in-hospital all-cause mortality. A total of 2,602,854 patients had a diagnosis of sepsis. AMI was diagnosed in 118,183 patients (4.5%), the majority with non-ST elevation AMI (71.4%). In-hospital mortality was higher in patients with AMI and sepsis than those with sepsis alone (35.8% vs 16.8%, p <0.0001; adjusted odds ratio 1.24, 95% CI 1.22 to 1.26). In patients with AMI, 11,899 patients (10.1%) underwent an invasive management strategy, in which 4,668 patients (39.2%) underwent revascularization. PCI was performed in 3,413 patients (73.1%), CABG in 1,165 (25.0%), and both CABG and PCI in 90 patients (1.9%). In a propensity-matched cohort of 23,708 patients with AMI, invasive management was associated with a lower mortality than conservative management (19.0% vs 33.4%, p <0.001; odds ratio 0.47, 95% CI 0.44 to 0.50). In subgroups that underwent revascularization, the odds of mortality were consistently lower than corresponding matched subjects from the conservative group. In conclusion, myocardial infarction not infrequently complicates sepsis and is associated with a significant increase in in-hospital mortality. Patients managed invasively had a lower mortality than those managed conservatively.
因脓毒症住院的患者可能易患急性心肌梗死(AMI)。脓毒症患者中AMI的发病率、治疗方法及预后尚未得到研究。我们分析了2002年至2011年国家住院患者样本中诊断为脓毒症患者的数据。评估了作为非主要诊断的AMI的发病率。采用倾向评分匹配法确定一组具有相似基线特征的继发性AMI和脓毒症患者队列,这些患者接受了侵入性治疗(定义为心脏导管插入术、经皮冠状动脉介入治疗[PCI]或冠状动脉旁路移植术[CABG]手术)或保守治疗。主要结局是院内全因死亡率。共有2602854例患者被诊断为脓毒症。118183例患者(4.5%)被诊断为AMI,其中大多数为非ST段抬高型AMI(71.4%)。AMI合并脓毒症患者的院内死亡率高于单纯脓毒症患者(35.8%对16.8%,p<0.0001;调整后的优势比为1.24,95%CI为1.22至1.26)。在AMI患者中,11899例患者(10.1%)接受了侵入性治疗策略,其中4668例患者(39.2%)接受了血运重建。3413例患者(73.1%)接受了PCI,1165例患者(25.0%)接受了CABG,90例患者(1.9%)同时接受了CABG和PCI。在23708例倾向评分匹配的AMI患者队列中,侵入性治疗与保守治疗相比死亡率较低(19.0%对33.4%,p<0.001;优势比为0.47,95%CI为0.44至0.50)。在接受血运重建的亚组中,死亡率的优势比始终低于保守治疗组的相应匹配对象。总之,心肌梗死常并发脓毒症,并与院内死亡率显著增加相关。接受侵入性治疗的患者死亡率低于接受保守治疗的患者。